Amyloid-Related Imaging Abnormalities in Anti-Amyloid Monoclonal Antibody Therapy for Alzheimer’s Disease: Expert Recommendation for Standard MRI Protocol
The introduction of anti-amyloid therapies for Alzheimer’s disease (AD), such as lecanemab (Lequembi ®), which was recently approved in Korea, necessitates careful monitoring for amyloid-related imaging abnormalities (ARIA) using brain MRI. To optimize ARIA monitoring in Korean clinical settings,...
Saved in:
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Society of Radiology
2025-01-01
|
Series: | Journal of the Korean Society of Radiology |
Subjects: | |
Online Access: | https://doi.org/10.3348/jksr.2024.0147 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|